The madness of a state that spends more on welfare than it raises from income tax April 7, 2026 If it were possible to buy Happy New Tax Year cards you’d surely find them stocked in the ‘With Sympathy’ section. As of yesterday, the state has increased its demands on a host of taxpayers. Dividend tax is up two per cent for basic and higher rate taxpayers, with the latter now hit by a [...]
OpenAI calls for ‘tax on automated labour’ as it sounds alarm on economic risks April 7, 2026 OpenAI has called for a tax on automated labour as the firm laid bare the scale of the structural risks to the global economy that could be wrought by the rise in artificial intelligence. In a wide-ranging set of proposals in a paper described as “Industrial Policy for the Intelligence Age”, the ChatGPT maker called [...]
Tax instability drives ultra-wealthy to pack their bags April 2, 2026 Tax instability has driven huge swathes of the UK’s ultra-wealthy to consider leaving the country over the past twelve months. Two-thirds of the UK’s wealthiest have mulled fleeing the country for tax reasons, according to the latest research from accountancy firm BDO. But while conversations surrounding tax have focused on the rate Britain’s wealthiest pay, [...]
‘Ridiculous’: Torsten Bell under fire over pension schemes bill April 2, 2026 London’s pension industry is in uproar over government proposals to keep what is known as ‘backstop power’ over the precise level of investment from funds in specific UK assets. Torsten Bell, the pensions minister, has become the focus of anger at Whitehall’s attempts to exert a degree of control over where some of the biggest [...]
Stealth taxes are rising – here’s how to protect your money before 5 April April 2, 2026 Niche taxes like inheritance tax and capital gains tax are fast becoming major cash cows for the treasury. Here’s what to do before the end of the tax year Britain’s stealth tax is accelerating, with more people being pulled into the net without realising it. The government is collecting more from capital gains tax (CGT) [...]
Ask the expert: How do I convert my property portfolio into a pension? April 2, 2026 Do you have a personal finance question that you’re struggling to find an answer to? Email askthexpert@cityam.com Questions will be published anonymously. Fidelity personal finance specialist Marianna Hunt is back to advise a reader who is looking to turn their property portfolio into pension income. Q: How do you convert an exclusively property portfolio into [...]
OpenAI investor calls for tax overhaul as AI reshapes jobs market March 29, 2026 An early investor in OpenAI has called for a radical overhaul of the US tax system in anticipation that the rise of AI will necessitate a shift from taxing labour to taxing capital. American businessman and venture capitalist Vinod Khosla has said that as the accelerated automation of the workforce fuels public anxiety over job [...]
A practical guide to buying Scotch whisky casks March 27, 2026 Vikki Bruce is co-founder and Managing Director of MacLean & Bruce, a Scotland-based specialist in luxury whisky experiences and cask broker. As an expert in Scotch whisky cask ownership and campaigner against fraud, she works closely with the Scotch whisky industry and advocates for greater transparency and regulation in the cask trading market. Over the [...]
Whisky investment in 2026: Structure, new markets and scarcity March 26, 2026 For investors seeking diversification in their portfolios to counter this era of stock market volatility and geopolitical pressures, the biggest takeaway is this: whisky investment has grown up. Premium spirits are no longer a niche asset characterised by the flipping of limited releases to make easy-money following the speculative surge during the pandemic. Instead, whisky [...]
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights March 24, 2026 COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved before Compass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4 Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launch Phase 2b/3 trial in PTSD initiating, following FDA acceptance of IND application Successful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028